Merck (MRK) Revenue (2009 - 2026)

Merck (MRK) has reported Revenue for 18 consecutive years, with $16.6 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue rose 5.07% year-over-year to $16.6 billion in Q2 2026; TTM through Jun 2026 was $66.6 billion, a 4.64% increase from a year earlier, with the FY2025 full-year figure at $65.0 billion, up 1.31% from the prior year.
• Revenue was $16.6 billion for Q2 2026 at Merck, up from $16.3 billion in the prior quarter.
• Over five years, Revenue peaked at $17.3 billion in Q3 2025 and troughed at $13.8 billion in Q4 2022.
• A 5-year average of $15.6 billion and a median of $15.8 billion in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue soared 49.63% in 2022 and slipped 8.89% in 2023, its largest moves.
• Over 5 years, Revenue stood at $13.8 billion in 2022, then rose by 5.78% to $14.6 billion in 2023, then advanced by 6.79% to $15.6 billion in 2024, then climbed by 4.97% to $16.4 billion in 2025, then advanced by 1.26% to $16.6 billion in 2026.
• The last three Revenue figures came in at $16.6 billion (Q2 2026), $16.3 billion (Q1 2026), and $16.4 billion (Q4 2025), per Business Quant data.